ID: ALA5079839

Max Phase: Preclinical

Molecular Formula: C42H58FN5O6S

Molecular Weight: 780.02

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CC(=O)N1CCC[C@H](S(=O)(=O)c2ccc(N3CC(CN4CCC([C@@](CN5CCC5)(c5cccc(F)c5)[C@H]5CCC[C@@H]5NC(=O)OC)CC4)(OC)C3)cc2)C1

Standard InChI:  InChI=1S/C42H58FN5O6S/c1-4-39(49)47-22-7-11-36(26-47)55(51,52)35-16-14-34(15-17-35)48-28-41(29-48,54-3)27-46-23-18-31(19-24-46)42(30-45-20-8-21-45,32-9-5-10-33(43)25-32)37-12-6-13-38(37)44-40(50)53-2/h4-5,9-10,14-17,25,31,36-38H,1,6-8,11-13,18-24,26-30H2,2-3H3,(H,44,50)/t36-,37-,38-,42-/m0/s1

Standard InChI Key:  XOGANROEWWVGCF-VEZYWKGHSA-N

Associated Targets(Human)

Menin 447 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MV4-11 7307 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MOLM-13 2241 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 780.02Molecular Weight (Monoisotopic): 779.4092AlogP: 4.86#Rotatable Bonds: 13
Polar Surface Area: 111.73Molecular Species: BASEHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.92CX LogP: 4.42CX LogD: 2.56
Aromatic Rings: 2Heavy Atoms: 55QED Weighted: 0.29Np Likeness Score: -0.84

References

1. Zhang M, Aguilar A, Xu S, Huang L, Chinnaswamy K, Sleger T, Wang B, Gross S, Nicolay BN, Ronseaux S, Harvey K, Wang Y, McEachern D, Kirchhoff PD, Liu Z, Stuckey J, Tron AE, Liu T, Wang S..  (2021)  Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression.,  64  (14.0): [PMID:34196551] [10.1021/acs.jmedchem.1c00789]

Source